PGAM1 Promotes Glycolytic Metabolism and Paclitaxel Resistance via Pyruvic Acid Production in Ovarian Cancer Cells
Background: Enhanced glycolysis occurs in most human cancer cells and is related to chemoresistance. However, detailed mechanisms remain vague. Methods: Using proteinomics analysis, we found that the glycolytic enzyme Phosphoglycerate mutase 1 (PGAM1) was highly expressed in the paclitaxel-resistant...
Main Authors: | Yan Feng, Xu Zhang, Songfa Zhang, Shanshan Xu, Xiaojing Chen, Caiyun Zhou, Yongmei Xi, Xing Xie, Weiguo Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2022-09-01
|
Series: | Frontiers in Bioscience-Landmark |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBL/27/9/10.31083/j.fbl2709262 |
Similar Items
-
The Design and Synthesis of N-Xanthone Benzenesulfonamides as Novel Phosphoglycerate Mutase 1 (PGAM1) Inhibitors
by: Penghui Wang, et al.
Published: (2018-06-01) -
Design, synthesis, and biological evaluation of benzenesulfonyl chloride-substituted evodiamine derivatives as potential PGAM1 inhibitors
by: Binbin Wei, et al.
Published: (2023-11-01) -
Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion
by: Yao-An Wen, et al.
Published: (2018-01-01) -
Sumoylation-deficient phosphoglycerate mutase 2 impairs myogenic differentiation
by: Yi Zhang, et al.
Published: (2022-12-01) -
Development of Anthraquinone Analogues as Phosphoglycerate Mutase 1 Inhibitors
by: Ke Huang, et al.
Published: (2019-02-01)